isoflurophate has been researched along with Marchiafava-Micheli Syndrome in 4 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HEIMPEL, H | 1 |
| KLUTHE, R | 1 |
| Pollycove, M | 1 |
| Tono, M | 1 |
| Atlas, SJ | 1 |
| Shapiro, B | 1 |
| Green, JW | 1 |
| Barkhan, P | 1 |
4 other studies available for isoflurophate and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
SERUM HAPTOGLOBIN AS RELATED TO RED CELL TURNOVER RATE ESTIMATED BY CR-51 OR DFP-32.
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Anemia, Hemolytic, Congenital Nonspherocyti | 1964 |
Studies of the erythron.
Topics: Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anemia, Hypochromic; Anemia, Pernicious; B | 1975 |
Surface properties of erythrocytes: normal, paroxysmal nocturnal hemoglobinuria and glutathione-treated cells.
Topics: Acetylcholinesterase; Benzenesulfonates; Binding Sites; Biological Transport; Cell Membrane; Electro | 1973 |
Platelet survival studies in man with diisopropylphosphorofluoridate (DF32P). Some observations in patients with hypocoagulability, 'hypercoagulability' and platelet disorders.
Topics: Adolescent; Adult; Aged; Aging; Anticoagulants; Arteriosclerosis; Blood Coagulation Disorders; Blood | 1966 |